Page 277 - New Silat Rules 2020

Laboratories

The purpose of the International Standard for Laboratories (ISL) is to ensure production of
valid test results and evidentiary data and to achieve uniform and harmonized results and
reporting from all accredited laboratories.

In addition, the ISL and its related Technical Documents specify the criteria that must be
fulfilled by anti-doping laboratories to achieve and maintain WADA accreditation.

Therapeutic Use Exemptions

The purpose of the International Standard for Therapeutic Use Exemptions (ISTUE) is to
ensure that the process of granting TUEs is harmonized across sports and countries.

Where the competitor already has a TUE granted by the Competitor’s National Anti-Doping
Organization, the International Federation or the Major Event Organizer will recognize it.
Unless if the IF or MEO decides that the TUE does not meet those criteria and so refuses to
recognize it, it must notify the competitor promptly and explain the reasons.

Protection of Privacy and Personal Information

On 1 June, WADA published a revised International Standard for the Protection of Privacy and
Personal Information (ISPPPI) that took effect immediately. The main purpose of the ISPPPI is
to ensure that organizations and persons involved in anti-doping in sport apply appropriate,
sufficient and effective privacy protections to personal data that they process.

Code Compliance by Signatories

The Code makes WADA responsible for monitoring and enforcing compliance by Signatories
with the Code and the International Standards. The Code also requires Signatories to report
on their compliance to WADA. The purpose of the International Standard for Code
Compliance by Signatories (ISCCS) is to ensure that strong, Code-compliant anti-doping rules
and programs are applied and enforced consistently and effectively across all sports and all
countries, so that clean athletes can have confidence that there is fair competition on a level
playing field, and public confidence in the integrity of sport can be maintained.

As stated from WADA;

“Any pharmacological substance which is not addressed by any of the subsequent sections of
the List and with no current approval by any governmental regulatory health authority for
human therapeutic use (e.g. drugs under preclinical or clinical development or discontinued,
designer drugs, substances approved only for veterinary use) is prohibited at all times.”

Prohibited substances are such as:

- anabolic agents
- peptide hormones, growth factors, related substances, mimetics
273